160 related articles for article (PubMed ID: 28255237)
1. Natural course of early COPD.
Rhee CK; Kim K; Yoon HK; Kim JA; Kim SH; Lee SH; Park YB; Jung KS; Yoo KH; Hwang YI
Int J Chron Obstruct Pulmon Dis; 2017; 12():663-668. PubMed ID: 28255237
[TBL] [Abstract][Full Text] [Related]
2. Comparative study on medical utilization and costs of chronic obstructive pulmonary disease with good lung function.
Lim JU; Kim K; Kim SH; Lee MG; Lee SY; Yoo KH; Lee SH; Jung KS; Rhee CK; Hwang YI
Int J Chron Obstruct Pulmon Dis; 2017; 12():2711-2721. PubMed ID: 28979113
[TBL] [Abstract][Full Text] [Related]
3. Identification of subtypes in subjects with mild-to-moderate airflow limitation and its clinical and socioeconomic implications.
Lee JH; Rhee CK; Kim K; Kim JA; Kim SH; Yoo KH; Kim WJ; Park YB; Park HY; Jung KS
Int J Chron Obstruct Pulmon Dis; 2017; 12():1135-1144. PubMed ID: 28442900
[TBL] [Abstract][Full Text] [Related]
4. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
[TBL] [Abstract][Full Text] [Related]
5. Health care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea.
Kim C; Yoo KH; Rhee CK; Yoon HK; Kim YS; Lee SW; Oh YM; Lee SD; Lee JH; Kim KJ; Kim JH; Park YB
Int J Tuberc Lung Dis; 2014 Jun; 18(6):737-43. PubMed ID: 24903947
[TBL] [Abstract][Full Text] [Related]
6. Hand grip strength and chronic obstructive pulmonary disease in Korea: an analysis in KNHANES VI.
Lee SH; Kim SJ; Han Y; Ryu YJ; Lee JH; Chang JH
Int J Chron Obstruct Pulmon Dis; 2017; 12():2313-2321. PubMed ID: 28831248
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of asthma and COPD overlap.
Kim MH; Rhee CK; Kim K; Kim SH; Lee JY; Kim YH; Yoo KH; Cho YJ; Jung KS; Lee JH
Int J Chron Obstruct Pulmon Dis; 2018; 13():1251-1260. PubMed ID: 29713158
[TBL] [Abstract][Full Text] [Related]
8. Trend of cost and utilization of COPD medication in Korea.
Lee J; Lee JH; Kim JA; Rhee CK
Int J Chron Obstruct Pulmon Dis; 2017; 12():27-33. PubMed ID: 28031708
[TBL] [Abstract][Full Text] [Related]
9. Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
Lee JK; Rhee CK; Kim K; Ra SW; Lee JH; Jung KS; Yoo KH; Kim YI; Kim DK
Int J Chron Obstruct Pulmon Dis; 2019; 14():2639-2647. PubMed ID: 31819397
[TBL] [Abstract][Full Text] [Related]
10. COPD exacerbation frequency and its association with health care resource utilization and costs.
Dhamane AD; Moretz C; Zhou Y; Burslem K; Saverno K; Jain G; Renda A; Kaila S
Int J Chron Obstruct Pulmon Dis; 2015; 10():2609-18. PubMed ID: 26664109
[TBL] [Abstract][Full Text] [Related]
11. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU
Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446
[TBL] [Abstract][Full Text] [Related]
12. Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population.
Moll K; Sun SX; Ellis JJ; Howe A; Amin A
Int J Chron Obstruct Pulmon Dis; 2015; 10():565-76. PubMed ID: 25834417
[TBL] [Abstract][Full Text] [Related]
13. Factors contributing to high-cost hospital care for patients with COPD.
Mulpuru S; McKay J; Ronksley PE; Thavorn K; Kobewka DM; Forster AJ
Int J Chron Obstruct Pulmon Dis; 2017; 12():989-995. PubMed ID: 28392683
[TBL] [Abstract][Full Text] [Related]
14. The Economic Effect of Early Management in Patients with Early Chronic Obstructive Pulmonary Disease: Results from a Population-Based Nationwide Survey.
Lee YS; Min KH; Rhee CK; Kim YH; Lim SY; Um SJ; Lee CH; Jung KS; Yoo KH
Lung; 2019 Jun; 197(3):303-313. PubMed ID: 30859313
[TBL] [Abstract][Full Text] [Related]
15. Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.
Montes de Oca M; Aguirre C; Lopez Varela MV; Laucho-Contreras ME; Casas A; Surmont F
Int J Chron Obstruct Pulmon Dis; 2016; 11():3059-3067. PubMed ID: 27994446
[TBL] [Abstract][Full Text] [Related]
16. Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease.
Miravitlles M; Huerta A; Valle M; García-Sidro P; Forné C; Crespo C; López-Campos JL
Int J Chron Obstruct Pulmon Dis; 2015; 10():367-77. PubMed ID: 25733826
[TBL] [Abstract][Full Text] [Related]
17. The use of the lower limit of normal as a criterion for COPD excludes patients with increased morbidity and high consumption of health-care resources.
Izquierdo Alonso JL; De Lucas Ramos P; Rodríguez Glez-Moro JM;
Arch Bronconeumol; 2012 Jul; 48(7):223-8. PubMed ID: 22480962
[TBL] [Abstract][Full Text] [Related]
18. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880
[TBL] [Abstract][Full Text] [Related]
19. COPD symptom burden: impact on health care resource utilization, and work and activity impairment.
Ding B; Small M; Bergström G; Holmgren U
Int J Chron Obstruct Pulmon Dis; 2017; 12():677-689. PubMed ID: 28260874
[TBL] [Abstract][Full Text] [Related]
20. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone.
Gerhardsson de Verdier M; Andersson M; Kern DM; Zhou S; Tunceli O
Value Health; 2015 Sep; 18(6):759-66. PubMed ID: 26409602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
